You are here: Industry Insights > cancer

News List

For Some, Follicular Lymphoma May Be Curable drugs
December 12, 2019
Some patients in remission from the blood?cancer?called?follicular lymphoma?can be considered cured, a new small study suggests.
Sanofi to acquire Synthorx for $2.5 B biospectrumasia
December 12, 2019
Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.
Insurance Disparities ID'd in Diagnosis of Late-Stage Melanoma drugs
December 12, 2019
For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with ...
Microcapsules provide targeted chemotherapy drug delivery to cancer cells europeanpharmaceuticalreview
December 12, 2019
Development of infrared light-sensitive microcapsules could be the future in targeted drug delivery for cancer treatment, says new research.
Merck to Acquire ArQule for $2.7B ContractPharma
December 11, 2019
Diversifies oncology pipeline with expansion into targeted therapies that treat hematological malignancies.
Dong-A ST and Beactica Therapeutics Achieve Key Milestone in Their Collaboration to Develop New Cancer Treatments biopharmadive
December 10, 2019
Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company...
ImCheck raises Series B funds to develop gamma delta therapies pharmaceutical-technology
December 09, 2019
French biotech firm ImCheck Therapeutics has raised $53m (€48m) in a Series B funding round to develop its gamma delta (γδ) T-cell-based antibodies to treat cancer and autoimmune disorders.
BitBiome to analyse gut bacteria related to cancer biospectrumasia
December 09, 2019
BitBiome, Inc., a start-up company from?Waseda University in Japan,?and National Cancer Center of?Japan?have signed a collaborative research agreement on the analysis of gut bacteria related to cancer on?November 22nd.
Apollo Hospitals' Unique Initiative to Provide Best Treatment Plan for Cancer Patients En-CPhI.CN
October 23, 2019
Cancer is the second leading cause of death globally and was responsible for over 9.6 million deaths in 2018 alone.
China's first self-developed carbon-ion therapy system gets market access NMPA
October 16, 2019
China's first self-developed carbon-ion therapy system has been approved by the national drug regulator and obtained market access.